Test Tools Sigler's 24th Edition Pharmacy Drug Cards

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

SFI Medical

Full Member
Vendor
10+ Year Member
15+ Year Member
Joined
May 2, 2007
Messages
27
Reaction score
0
Published in mid/late 2008, the 24th edition of the Prescription drug cards covers the Top 300 drugs prescribed in the United States. SFI Medical Publishing has been in business for nearly 25 years, and our products are used by most pharmacy schools in the US, as well as several pharmacy tech programs and nursing programs. Our study guides are useful for on-the-go studying, exams, and quick reference. The cards come in a convenient 3-ring binder for ease-of-use and can be taken out and arranged as the user requires.

New for this edition, the cards come in alphabetical order by generic name, as opposed to trade name in past editions. After much consideration and input from our customers, we decided to make this transition as it seems more convenient for most users.

The study guides also include the following information:
  • Generic Name (with pronunciation)
  • Trade name
  • Full color photograph
  • Dosage Forms
  • FDA Indications/Dosages
  • Color-coded therapeutic class, with legend
  • Pharmacology/Pharmacokinetics
  • Drug Interactions
  • Contraindications/Precautions
  • Adverse Effects
  • Patient Consultation information
  • Chemical Structure

The prescription drug cards are normally $49.95 (within the US) but as a special promotion, we are offering Student Doctor Network users a 15% discount! To receive this special offer, please order by phone at 1-800-446-6293. Please mention the offer code SDN15. This promotion will only run through January 31.

You can visit our website at www.siglerdrugcards.com for more information, but the discount will not be calculated unless you call our toll free number!

We would like to thank you for being a part of test prep week, and we look forward to hearing from you soon! :D

Members don't see this ad.
 
Last edited:
Top